Albert Fung

Evaluation of Bone Mineral Density and Bone Biomarkers in Patients With Type 2 Diabetes Treated With Canagliflozin

John P. Bilezikian, Nelson B. Watts, Keith Usiskin et al. · The Journal of Clinical Endocrinology & Metabolism · 2015 · 266 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Efficacy and Safety of Canagliflozin Treatment in Older Subjects With Type 2 Diabetes Mellitus: A Randomized Trial

Bruce W. Bode, Kaj Stenlöf, Daniel J. Sullivan et al. · Hospital Practice · 2013 · 239 citations

Medicine, Pharmacology, Pharmacotherapy +17

Long‐term efficacy and safety of canagliflozin over 104 weeks in patients aged 55–80 years with type 2 diabetes

Bruce W. Bode, Kaj Stenlöf, Stewart B. Harris et al. · Diabetes Obesity and Metabolism · 2014 · 232 citations

Medicine, Pharmacology, Pharmacotherapy +17

Genital mycotic infections with canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus: a pooled analysis of clinical studies

Paul Nyirjesy, Jack D. Sobel, Albert Fung et al. · Current Medical Research and Opinion · 2014 · 136 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Effect of Canagliflozin on Blood Pressure and Adverse Events Related to Osmotic Diuresis and Reduced Intravascular Volume in Patients With Type 2 Diabetes Mellitus

Matthew R. Weir, Andrzej Januszewicz, Richard E. Gilbert et al. · Journal of Clinical Hypertension · 2014 · 119 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17